Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 0.12% | 283.74 | 1.5% | $847.25m | |
| GILD | Gilead Sciences, Inc. | 0.98% | 86.26 | 1.0% | $795.01m | |
| MRNA | Moderna, Inc. | -0.23% | 176.40 | 0.0% | $769.19m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.01% | 312.98 | 1.9% | $482.01m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.12% | 736.23 | 2.6% | $473.28m | |
| BIIB | Biogen, Inc. | 0.56% | 305.15 | 1.8% | $355.07m | |
| ILMN | Illumina, Inc. | -1.39% | 218.99 | 3.2% | $270.73m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 5.70% | 2.78 | 0.7% | $194.33m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.89% | 96.92 | 4.2% | $161.47m | |
| BNTX | BioNTech SE | -0.88% | 154.85 | 0.0% | $152.12m | |
| MRTX | Mirati Therapeutics, Inc. | 2.89% | 98.62 | 1.6% | $132.21m | |
| TECH | Bio-Techne Corp. | 0.79% | 338.97 | 4.5% | $123.89m | |
| AXSM | Axsome Therapeutics, Inc. | 1.07% | 56.82 | 1.6% | $80.71m | |
| NVAX | Novavax, Inc. | -2.88% | 16.54 | 75.3% | $70.44m | |
| HALO | Halozyme Therapeutics, Inc. | 0.59% | 54.67 | 18.4% | $64.50m |
Company Profile
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.